Published in J Immunol on August 15, 1998
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology (2005) 3.18
Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med (2002) 1.95
The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest (2001) 1.82
Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med (2001) 1.74
A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med (2008) 1.67
Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev (2008) 1.49
Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol Rev (2009) 1.44
Localization of the gD-binding region of the human herpes simplex virus receptor, HveA. J Virol (2001) 1.21
Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest (2001) 1.16
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling. J Leukoc Biol (2010) 1.15
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease. J Clin Invest (2002) 1.07
Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners. Semin Immunopathol (2009) 0.96
Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infection. PLoS One (2011) 0.92
Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev (2008) 0.87
LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. Oncotarget (2014) 0.86
Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia. Hypertension (2013) 0.86
Differential expression of LIGHT and its receptors in human placental villi and amniochorion membranes. Am J Pathol (2002) 0.85
TNF superfamily: costimulation and clinical applications. Cell Biol Int (2009) 0.83
Increased plasma LIGHT levels in patients with atopic dermatitis. Clin Exp Immunol (2012) 0.81
Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. Microbes Infect (2014) 0.81
Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells. Gastric Cancer (2012) 0.81
CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALING. Eur J Microbiol Immunol (Bp) (2011) 0.81
Improvement in efficacy of DNA vaccine encoding HIV-1 Vif by LIGHT gene adjuvant. Viral Immunol (2013) 0.79
Role of TNFR-related 2 mediated immune responses in dextran sulfate sodium-induced inflammatory bowel disease. Mol Cells (2011) 0.78
Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma. Oncotarget (2017) 0.75
Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis. World J Exp Med (2017) 0.75
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62
Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature (1985) 5.06
Mortality from lung cancer and other causes among workers in an asbestos textile factory. Br J Ind Med (1968) 4.81
Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81
Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44
Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A (1996) 4.19
Analysis of the Saccharomyces spindle pole by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. J Cell Biol (1998) 4.08
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Caution in use of bicortical intermaxillary fixation screws. Br J Oral Maxillofac Surg (2000) 3.71
Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology (1996) 3.60
Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A (1999) 3.42
How damaged is the biologically active subpopulation of transfected DNA? Mol Cell Biol (1984) 2.88
Malpractice claims against family physicians are the best doctors sued more? J Fam Pract (1999) 2.87
AtHKT1 is a salt tolerance determinant that controls Na(+) entry into plant roots. Proc Natl Acad Sci U S A (2001) 2.75
Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature (1994) 2.63
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55
SSC1, an essential member of the yeast HSP70 multigene family, encodes a mitochondrial protein. Mol Cell Biol (1989) 2.52
Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem (1993) 2.51
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
Natural occurrence of cross-linked vaccinia virus deoxyribonucleic acid. J Virol (1970) 2.41
Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
Application of finite element analysis in implant dentistry: a review of the literature. J Prosthet Dent (2001) 2.33
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A (1996) 2.32
Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem (2000) 2.24
A statement on the generalist physician from the American Boards of Family Practice and Internal Medicine. JAMA (1994) 2.16
Structural proteins of simian virus 40: phosphoproteins. J Virol (1972) 2.16
Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A (2000) 2.16
5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther (1991) 2.14
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Case-control study of stroke and the quality of hypertension control in north west England. BMJ (1997) 2.10
Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol (1996) 2.09
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
Opportunistic and reprehensible. Br Dent J (2006) 2.01
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00
Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun (1997) 1.99
The relationship between depressive symptoms and cigarette smoking in US adolescents. Addiction (1998) 1.98
Characterization of Giemsa dark- and light-band DNA. Cell (1982) 1.96
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem (1988) 1.95
Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem (1990) 1.94
Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem (1999) 1.94
Structural basis of inhibitor selectivity in MAP kinases. Structure (1998) 1.89
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team. JAMA (1997) 1.78
Performances of family practice diplomates on successive mandatory recertification examinations. Acad Med (1993) 1.75
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem (2001) 1.72
Chronic anal ulceration due to nicorandil. Br J Dermatol (2005) 1.72
Participatory design and an eligibility screening tool. Proc AMIA Symp (2000) 1.69
Intragenic amplification and divergence in the mouse alpha-fetoprotein gene. Nature (1981) 1.69
A simple device for fractionating density gradients. Anal Biochem (1972) 1.68
A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett (1996) 1.68
Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J Biol Chem (2000) 1.68
Asbestosis: a study of dose-response relationships in an asbestos textile factory. Br J Ind Med (1979) 1.63
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem (1998) 1.60
Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci U S A (1989) 1.58
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
Role of intra- and extracellular calcium in histamine release from rat peritoneal mast cells. Agents Actions (1981) 1.53
Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr (1999) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Iodine-131 in breast milk following therapy for thyroid carcinoma. J Nucl Med (1994) 1.51
Transcriptional control of the expression of mouse globin genes in myeloma x erythroleukemia cell hybrids. Somatic Cell Genet (1982) 1.50
Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J Virol (2000) 1.49
Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol (2006) 1.48
The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem (2000) 1.47
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol (2000) 1.46
Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol (1996) 1.45
Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol (1994) 1.43
Colchicine in acute gout: the need for a reappraisal. Int J Clin Pract (2007) 1.43
A role for centrin 3 in centrosome reproduction. J Cell Biol (2000) 1.43
Semliki forest virus temperature-sensitive mutants: isolation and characterization. Virology (1969) 1.42
Extracardiac modification of the Fontan operation without use of prosthetic material. J Thorac Cardiovasc Surg (1995) 1.42
The interaction of intercalating drugs with nucleic acids. Annu Rev Biophys Bioeng (1981) 1.42
Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol (2000) 1.42
Lichen nitidus and lichen spinulosus or spinous follicular lichen nitidus? Clin Exp Dermatol (2005) 1.41
A true craniomaxillary fracture. Br J Oral Maxillofac Surg (2001) 1.41
Prenatal care--a serious national dilemma. J Am Board Fam Pract (1990) 1.41
Construction and expression in vivo of an internally deleted mouse alpha-fetoprotein gene: presence of a transcribed Alu-like repeat within the first intervening sequence. Nucleic Acids Res (1982) 1.40